Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 102, Issue 2, 2014, Pages

  Kim, Ji Won ^a   Kang, Kyung Min ^a   Yoon, Tae Ki ^a   Shim, Sung Han ^a   Lee, Woo Sik ^a  

^a CHA University   (South Korea)

Author keywords

BMP 6; hepcidin; iron excess; metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; BONE MORPHOGENETIC PROTEIN 6; C REACTIVE PROTEIN; CHOLESTEROL; FERRITIN; HEMOGLOBIN; HEPCIDIN; INSULIN; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; RNA; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENDOCRINE FUNCTION TEST; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRANULOSA CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; IRON BLOOD LEVEL; IRON METABOLISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUATION; METABOLIC SYNDROME X; OBESITY; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

BMP-6; HEPCIDIN; IRON EXCESS; METABOLIC SYNDROME; POLYCYSTIC OVARY SYNDROME;

ADULT; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 6; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GRANULOSA CELLS; HEPCIDINS; HUMANS; IRON; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84905507411     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.04.031     Document Type: Article

References (37)

1. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245
2. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
3. A. Dunaif Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800
4. A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. Vanvoorhis, and D.H. Jagasia Screening women with polycystic ovary syndrome for metabolic syndrome Obstet Gynecol 106 2005 131 137
5. R. Azziz How prevalent is metabolic syndrome in women with polycystic ovary syndrome? Nat Clin Pract Endocrinol Metab 2 2006 132 133
6. P.A. Essah, and J.E. Nestler The metabolic syndrome in polycystic ovary syndrome J Endocrinol Invest 29 2006 270 280
7. H.F. Escobar-Morreale, M. Luque-Ramirez, F. Alvarez-Blasco, J.I. Botella-Carretero, J. Sancho, and J.L. San Millan Body iron stores are increased in overweight and obese women with polycystic ovary syndrome Diabetes Care 28 2005 2042 2044
8. M.A. Martinez-Garcia, M. Luque-Ramirez, J.L. San-Millan, and H.F. Escobar-Morreale Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism Diabetes Care 32 2009 1525 1530
9. J.M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart Cross-talk between iron metabolism and diabetes Diabetes 51 2002 2348 2354
10. W.H. Sheu, Y.T. Chen, W.J. Lee, C.W. Wang, and L.Y. Lin A relationship between serum ferritin and the insulin resistance syndrome is present in nondiabetic women but not in nondiabetic men Clin Endocrinol (Oxf) 58 2003 380 385
11. T. Ganz, and E. Nemeth Regulation of iron acquisition and iron distribution in mammals Biochim Biophys Acta 1763 2006 690 699
12. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, and D.M. Ward et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
13. L. Viatte, and S. Vaulont Hepcidin, the iron watcher Biochimie 91 2009 1223 1228
14. D. Meynard, L. Kautz, V. Darnaud, F. Canonne-Hergaux, H. Coppin, and M.P. Roth Lack of the bone morphogenetic protein BMP6 induces massive iron overload Nat Genet 41 2009 478 481
15. B. Andriopoulos Jr., E. Corradini, Y. Xia, S.A. Faasse, S. Chen, and L. Grgurevic et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism Nat Genet 41 2009 482 487
16. P.G. Knight, and C. Glister TGF-beta superfamily members and ovarian follicle development Reproduction 132 2006 191 206
17. J. Shi, O. Yoshino, Y. Osuga, K. Koga, Y. Hirota, and T. Hirata et al. Bone morphogenetic protein-6 stimulates gene expression of follicle-stimulating hormone receptor, inhibin/activin beta subunits, and anti-Mullerian hormone in human granulosa cells Fertil Steril 92 2009 1794 1798
18. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
19. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
20. S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, and R. Kahn et al. Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
21. M.C. Lansang, G.H. Williams, and J.S. Carroll Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension Am J Hypertens 14 2001 51 53
22. D.H. Choi, W.S. Lee, M. Won, M. Park, H.O. Park, and E. Kim et al. The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis J Proteome Res 9 2010 4329 4336
23. H.F. Escobar-Morreale, and M. Luque-Ramirez Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome Fertil Steril 95 2011 1730 1735.e1
24. I.C. Macdougall, J. Malyszko, R.C. Hider, and S.S. Bansal Current status of the measurement of blood hepcidin levels in chronic kidney disease Clin J Am Soc Nephrol 5 2010 1681 1689
25. M. Luque-Ramirez, F. Alvarez-Blasco, M. Alpanes, and H.F. Escobar-Morreale Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome J Clin Endocrinol Metab 96 2011 846 852
26. E. Gozdemir, I. Kaygusuz, and H. Kafali Is hepcidin a new cardiovascular risk marker in polycystic ovary syndrome? Gynecol Obstet Invest 75 2013 196 202
27. C. Datz, T.K. Felder, D. Niederseer, and E. Aigner Iron homeostasis in the metabolic syndrome Eur J Clin Invest 43 2013 215 224
28. T. Ganz Iron homeostasis: fitting the puzzle pieces together Cell Metab 7 2008 288 290
29. S. Bekri, P. Gual, R. Anty, N. Luciani, M. Dahman, and B. Ramesh et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH Gastroenterology 131 2006 788 796
30. M. Sanad, M. Osman, and A. Gharib Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study Ital J Pediatr 37 2011 34
31. X. Chen, R. Ni, Y. Mo, L. Li, and D. Yang Appropriate BMI levels for PCOS patients in southern China Hum Reprod 25 2010 1295 1302
32. O.A. Mojiminiyi, R. Marouf, and N.A. Abdella Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes Nutr Metab Cardiovasc Dis 18 2008 559 566
33. G. le Guenno, E. Chanseaume, M. Ruivard, B. Morio, and A. Mazur Study of iron metabolism disturbances in an animal model of insulin resistance Diabetes Res Clin Pract 77 2007 363 370
34. D. Barisani, S. Pelucchi, R. Mariani, S. Galimberti, P. Trombini, and D. Fumagalli et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload J Hepatol 49 2008 123 133
35. M. Ruivard, F. Laine, T. Ganz, G. Olbina, M. Westerman, and E. Nemeth et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin J Hepatol 50 2009 1219 1225
36. J.L. Babitt, F.W. Huang, Y. Xia, Y. Sidis, N.C. Andrews, and H.Y. Lin Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance J Clin Invest 117 2007 1933 1939
37. M. Khalaf, J. Morera, A. Bourret, Y. Reznik, C. Denoual, and M. Herlicoviez et al. BMP system expression in GCs from polycystic ovary syndrome women and the in vitro effects of BMP4, BMP6, and BMP7 on GC steroidogenesis Eur J Endocrinol 168 2013 437 444